Tomoya Kubota

ORCID: 0000-0003-1004-8537
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ion channel regulation and function
  • Cardiac electrophysiology and arrhythmias
  • Genetic Neurodegenerative Diseases
  • Myasthenia Gravis and Thymoma
  • Nicotinic Acetylcholine Receptors Study
  • Nanopore and Nanochannel Transport Studies
  • Neuroscience and Neural Engineering
  • Parkinson's Disease and Spinal Disorders
  • Mitochondrial Function and Pathology
  • Antifungal resistance and susceptibility
  • Peripheral Neuropathies and Disorders
  • Neuroscience and Neuropharmacology Research
  • Ion Transport and Channel Regulation
  • Parkinson's Disease Mechanisms and Treatments
  • Advanced biosensing and bioanalysis techniques
  • Electrostatics and Colloid Interactions
  • RNA and protein synthesis mechanisms
  • Electrochemical Analysis and Applications
  • RNA Research and Splicing
  • Chemical Synthesis and Analysis
  • Muscle Physiology and Disorders
  • Natural product bioactivities and synthesis
  • Mental Health and Patient Involvement
  • Railway Systems and Energy Efficiency
  • Traditional and Medicinal Uses of Annonaceae

Osaka University
2015-2024

Kubota (Japan)
2008-2024

Toho University Ohashi Medical Center
2024

Toho University
2024

Tokyo Medical University
2024

Keio University
2024

Osaka Metropolitan University
2024

Nagoya University
2021

University of Chicago
2012-2020

Nara Institute of Science and Technology
2020

James F. Howard Saskia Bresch Angela Genge Channa Hewamadduma John L. Hinton and 95 more Yessar Hussain Raúl Juntas‐Morales Henry J. Kaminski Angelina Maniaol Renato Mantegazza Masayuki Masuda Kumaraswamy Sivakumar Marek Śmiłowski Kimiaki Utsugisawa Tuan Vu Michael D. Weiss Małgorzata Zajda Babak Boroojerdi Melissa Brock Guillemette de la Borderie Petra W. Duda Romana Lowcock Mark Vanderkelen Maria Isabel Leite Dylan Sembinelli Jeanne Teitelbaum Michael Nicolle E Bernard Juliette Svahn Marco Spinazzi Tanya Stojkovic Sophie Demeret Nicolas Weiss Loïc Le Guennec Sihame Messai Christine Tranchant Aleksandra Nadaj‐Pakleza Jean‐Baptiste Chanson Muhtadi Suliman Leila Zaidi Céline Tard Peggy Lecointe Jana Zschüntzsch Jens Schmidt Stefanie Glaubitz Rachel Zeng Matthias Scholl Markus C. Kowarik Ulf Ziemann Markus Krumbholz Pascal Martin Christoph Ruschil Jutta Dünschede Roswitha Kemmner Natalie Rumpel Benjamin Berger Andreas Totzeck Tim Hagenacker Benjamin Stolte Raffaele Iorio Amelia Evoli Silvia Falso Carlo Antozzi Rita Frangiamore Fiammetta Vanoli Elena Rinaldi Kazushi Deguchi Naoya Minami Yuriko Nagane Yasushi Suzuki Sayaka Ishida Shigeaki Suzuki Jin Nakahara Astushi Nagaoka Shunsuke Yoshimura Shingo Konno Youko Tsuya Akiyuki Uzawa Tomoya Kubota Masanori Takahashi Tatsusada Okuno Hiroyuki Murai Nils Erik Gilhus Marion Boldingh Tone Hakvåg Rønning Urszula Chyrchel-Paszkiewicz Klaudiusz Kumor Tomasz Zieliński Krzysztof Banaszkiewicz Michał Błaż Agata Kłósek Mariola Matysiak Andrzej Szczudlik Aneta Paśko L Szczechowski Marta Banach Jan Ilkowski S. Kapetanovic García Patricia Ortiz Bagan Ana Belén Cánovas Segura

10.1016/s1474-4422(23)00080-7 article EN The Lancet Neurology 2023-04-13

Despite a growing number of ion channel genes implicated in hereditary ataxia, it remains unclear how mutations lead to loss-of-function or death cerebellar neurons. Mutations the gene KCNMA1, encoding α-subunit BK have emerged as responsible for variety neurological phenotypes. We describe mutation (BKG354S) child with congenital and progressive ataxia cognitive impairment. The selectivity filter dramatically reduced single-channel conductance selectivity. BKG354S trafficked normally...

10.1073/pnas.1920008117 article EN Proceedings of the National Academy of Sciences 2020-03-04

Background Early fast-acting treatment (EFT) is the aggressive use of therapies such as plasmapheresis, intravenous immunoglobulin and/or high-dose methylprednisolone (IVMP) from early phases treatment. EFT reportedly beneficial for achievement minimal manifestations (MM) or better status with ≤5 mg/day prednisolone (MM5mg), a practical therapeutic target myasthenia gravis (MG). Objective The current study aimed to clarify which specific regimen efficacious and patient characteristics that...

10.1136/jnnp-2022-330519 article EN Journal of Neurology Neurosurgery & Psychiatry 2023-01-24

Efgartigimod, which has been well tolerated and efficacious in individuals with generalized myasthenia gravis (MG), is available Japan not only for the treatment of anti-acetylcholine receptor-positive (AChR+) but also anti-muscle-specific receptor tyrosine kinase (MuSK+) seronegative MG. We report details use efgartigimod MG clinical practice Japan.

10.1212/cpj.0000000000200276 article EN Neurology Clinical Practice 2024-03-25

Abstract Objective Eculizumab and ravulizumab are complement protein C5 inhibitors, showing efficacy tolerability for patients with anti‐acetylcholine receptor‐positive (AChR+) generalized myasthenia gravis (gMG) in phase 3 clinical trials subsequent analyses. The purpose of the present study was to evaluate significance eculizumab switching refractory AChR+ gMG real‐world experience. Methods Among database Japan MG registry survey 2021, we studied who received eculizumab. We also evaluated...

10.1002/acn3.52051 article EN cc-by Annals of Clinical and Translational Neurology 2024-04-04

We have re-examined the utility of native chemical ligation at -Gln/Glu-Cys- [Glx-Cys] and -Asn/Asp-Cys- [Asx-Cys] sites. Using improved thioaryl catalyst 4-mercaptophenylacetic acid (MPAA), could be performed -Gln-Cys- Asn-Cys- sites without side reactions. After optimization, a -Glu-Cys- site also used as site, with minimal levels byproduct formation. However, -Asp-Cys- is not appropriate for use because formation significant amounts β-linked byproduct. The feasibility enabled convergent...

10.1021/ja4046795 article EN Journal of the American Chemical Society 2013-07-12

<h3>Objective:</h3> To identify other causative genes for Andersen–Tawil syndrome, which is characterized by a triad of periodic paralysis, cardiac arrhythmia, and dysmorphic features. syndrome caused in majority cases mutations <i>KCNJ2</i>, encodes the Kir2.1 subunit inwardly rectifying potassium channel. <h3>Methods:</h3> The proband exhibited episodic flaccid weakness characteristic TU-wave pattern, both suggestive but did not harbor <i>KCNJ2</i> mutations. We performed exome capture...

10.1212/wnl.0000000000000239 article EN Neurology 2014-02-27

Parasitic plants form a specialized organ, haustorium, to invade host tissues and acquire water nutrients. To understand the molecular mechanism of haustorium development, we performed forward genetics screening isolate mutants exhibiting haustorial defects in model parasitic plant Phtheirospermum japonicum. We isolated two that show prolonged sometimes aberrant meristematic activity apex, resulting severe on invasion. Whole-genome sequencing revealed respectively have point mutations...

10.1126/sciadv.abc2385 article EN cc-by-nc Science Advances 2020-10-28

Significance Physical activities of our body and extremities are achieved by the propagation electrical signals called action potentials from brain, through nerves, to skeletal muscles. Voltage-gated sodium channel (Navs) play essential roles in generation such excitable cells. Although mammalian Nav function has been studied comprehensively, precise structural basis for gating mechanisms not fully clarified. In this study, we have used lanthanide-based resonance energy transfer obtain...

10.1073/pnas.1700453114 article EN Proceedings of the National Academy of Sciences 2017-02-15

Abstract The primary purpose of the Japanese myasthenia gravis registry (JAMG‐R) has been to research and promote high‐quality medical care for MG patients in Japan. We reviewed findings surveys performed by JAMG‐R over an ~10‐y period. first goal favorable quality life (QOL) is a status minimal manifestations (MM) or better with oral prednisolone (PSL) dose 5 mg/d less (MM‐5 mg). E arly aggressive use nonoral f ast‐acting t reatment together low‐dose PSL (the “EFT strategy”) recommended...

10.1111/cen3.12731 article EN cc-by-nc Clinical and Experimental Neuroimmunology 2022-10-01

<b>Background: </b> Myotonic dystrophy type 1 (DM1) is a multisystemic disorder caused by CTG repeat expansion in the <i>DMPK</i> gene. Aberrant messenger RNA (mRNA) splicing of several genes has been reported to explain some symptoms DM1, but cause muscle wasting still unknown. By contrast, many forms muscular are abnormalities dystrophin–glycoprotein complex (DGC). α-Dystrobrevin key component DGC striated and plays important roles maturation signal transduction interacting with...

10.1212/01.wnl.0000302174.08951.cf article EN Neurology 2008-02-25

Abstract Myotonia manifests in several hereditary diseases, including hyperkalemic periodic paralysis (HyperPP), paramyotonia congenita (PMC), and potassium‐aggravated myotonia (PAM). These are allelic disorders originating from missense mutations the gene that codes skeletal muscle sodium channel, Nav1.4. Moreover, a severe form of PAM has been designated as permanens. A new mutation Nav1.4, Q1633E, was identified Japanese family presenting with phenotype. The proband suffered cyanotic...

10.1002/mus.21155 article EN Muscle & Nerve 2009-04-03

Non-motor symptoms in myasthenia gravis (MG) are rarely confirmed. Although there some small cohort studies, a large-systemic survey has not yet been performed.

10.1186/s12883-024-03644-w article EN cc-by BMC Neurology 2024-04-25

Abstract Ts1 toxin is a protein found in the venom of Brazilian scorpion Tityus serrulatus. binds to domain II voltage sensor voltage‐gated sodium channel Nav and modifies its dependence. In work reported here, we established an efficient total chemical synthesis using modern ligation methods demonstrated that it was fully active modifying dependence rat skeletal muscle rNav1.4 expressed oocytes. Total combined with click chemistry used label molecule fluorescent dyes Alexa‐Fluor 488 Bodipy....

10.1002/anie.201404438 article EN Angewandte Chemie International Edition 2014-07-02

Motions of circular and linear DNA molecules various lengths near a nanopore 100 or 200 nm diameter were experimentally observed investigated by fluorescence microscopy. The movement through nanopores, known as translocation, is mainly driven electric fields inside the pores. We found significant clogging nanopores molecules, particularly T4 (165.65 kbp). Here, probabilities events, depending on length shape-linear circular-were determined. Furthermore, two distinct motions observed: clog...

10.3390/polym11010084 article EN Polymers 2019-01-07

Abstract Background The role of patients in medical research is changing, as more emphasis being placed on patient involvement, and reported outcomes are increasingly contributing to clinical decision-making. Information communication technology provides new opportunities for actively become involved research. These trends particularly noticeable Europe the US, but less obvious Japan. aim this study was investigate practice active involvement Japan by utilizing a digital platform, analyze...

10.1186/s40900-021-00253-6 article EN cc-by Research Involvement and Engagement 2021-02-01

Many mutations in the skeletal-muscle sodium-channel gene SCN4A have been associated with myotonia and/or periodic paralysis, but so far all of these are located exons. We found a patient caused by deletion/insertion intron 21 SCN4A, which is an AT-AC type II intron. This rare class introns that, despite having boundaries, spliced major or U2-type spliceosome. The patient's skeletal muscle expressed aberrantly mRNA isoforms generated activation cryptic splice sites. In addition, genetic...

10.1002/humu.21501 article EN Human Mutation 2011-03-15

Abstract Ts3 is an alpha scorpion toxin from the venom of Brazilian Tityus serrulatus . binds to domain IV voltage sensor voltage‐gated sodium channels (Na v ) and slows down their fast inactivation. The covalent structure uncertain, folded protein molecule unknown. Herein, we report total chemical synthesis four candidate molecules results structure–activity studies that enabled us establish biologically active toxin. We also mirror image form molecule, use racemic crystallography determine...

10.1002/anie.201603420 article EN Angewandte Chemie International Edition 2016-05-31

To elucidate mutation spectrum and genotype-phenotype correlations in Japanese patients with OI, we conducted comprehensive genetic analyses using NGS, as this had not been analyzed comprehensively patient population. Most mutations were located on COL1A1 COL1A2. Glycine substitutions resulted the severe phenotype.Most cases of osteogenesis imperfecta (OI) are caused by or COL1A2, which encode α chains type I collagen. However, at least 16 other genes also cause OI. The OI has analyzed, it...

10.1007/s00198-019-05076-6 article EN cc-by-nc Osteoporosis International 2019-07-29
Coming Soon ...